Michael Brownlee
Impact in
- Clinical Biochemistry top 0.01%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Advanced Glycation End Products research 17
- Aging 2
- Co-authors
- Diane EdelsteinIda GiardinoYasufumi KanedaHans‐Peter HammesTakeshi NishikawaTakeshi MatsumuraXue DuMark A. Yorek
- Journals
- Diabetes (10 papers)Journal of Clinical Investigation (7 papers)Diabetologia (4 papers)The Journal of Experimental Medicine (3 papers)Journal of Critical Care (3 papers)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Michael Brownlee
58 papers receiving 12.4k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Clinical Biochemistry 4.3k
- Endocrinology, Diabetes and Metabolism 3.3k
- Physiology 3.2k
- Nephrology 772
- Ophthalmology 796
Countries citing papers authored by Michael Brownlee
This map shows the geographic impact of Michael Brownlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brownlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brownlee more than expected).
Fields of papers citing papers by Michael Brownlee
This network shows the impact of papers produced by Michael Brownlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brownlee. The network helps show where Michael Brownlee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Brownlee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 5 | |
| 4 | 2018 | 9 | |
| 5 | 2017 | 24 | |
| 6 | 2010 | 22 | |
| 7 | Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia Hit paper breakdown → | 2008 | 851 |
| 8 | 2008 | 52 | |
| 9 | 2001 | 58 | |
| 10 | 2001 | 148 | |
| 11 | Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Hit paper breakdown → | 2000 | 3428 |
| 12 | Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. | 1996 | 84 |
| 13 | 1996 | 9 | |
| 14 | 1994 | 26 | |
| 15 | 1994 | 241 | |
| 16 | 1994 | 287 | |
| 17 | 1992 | 25 | |
| 18 | Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes Hit paper breakdown → | 1990 | 570 |
| 19 | 1984 | 114 | |
| 20 | 1983 | 125 |
About Michael Brownlee
Michael Brownlee is a scholar working on Clinical Biochemistry, Aging, Immunology and Allergy, Nephrology and Ophthalmology, having authored 58 papers that have together received 12.8k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (17 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Cell Adhesion Molecules Research (6 papers), Pancreatic function and diabetes (6 papers), Glycosylation and Glycoproteins Research (5 papers), Retinal Diseases and Treatments (5 papers), Chronic Kidney Disease and Diabetes (5 papers) and Diabetes and associated disorders (5 papers). The work is most often cited by research in Clinical Biochemistry (4.3k citations), Endocrinology, Diabetes and Metabolism (3.3k citations), Physiology (3.2k citations), Nephrology (772 citations) and Ophthalmology (796 citations). Michael Brownlee has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Diane Edelstein, Ida Giardino, Yasufumi Kaneda, Hans‐Peter Hammes, Takeshi Nishikawa, Takeshi Matsumura, Xue Du, Mark A. Yorek, David A. Beebe and Peter J. Oates. Their work appears in journals such as Diabetes, Journal of Clinical Investigation, Diabetologia, The Journal of Experimental Medicine and Journal of Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.